Biotech Acquisition (NASDAQ:BIOT – Get Rating) was the target of a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 1,100 shares, an increase of 10.0% from the August 15th total of 1,000 shares. Based on an average daily volume of 123,500 shares, the days-to-cover ratio is presently 0.0 days.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. bought a new stake in Biotech Acquisition in the second quarter worth $19,966,000. Hudson Bay Capital Management LP boosted its stake in Biotech Acquisition by 147.5% in the 2nd quarter. Hudson Bay Capital Management LP now owns 1,261,609 shares of the company’s stock worth $12,490,000 after purchasing an additional 751,824 shares in the last quarter. Aristeia Capital LLC purchased a new stake in Biotech Acquisition during the 4th quarter valued at about $11,306,000. D. E. Shaw & Co. Inc. increased its stake in Biotech Acquisition by 75.4% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 929,085 shares of the company’s stock valued at $9,142,000 after purchasing an additional 399,255 shares in the last quarter. Finally, Omni Event Management Ltd raised its holdings in Biotech Acquisition by 25.4% in the first quarter. Omni Event Management Ltd now owns 844,965 shares of the company’s stock worth $8,331,000 after buying an additional 171,411 shares during the last quarter. Institutional investors own 86.02% of the company’s stock.
Biotech Acquisition Stock Performance
BIOT stock opened at $9.91 on Wednesday. The firm has a 50 day moving average price of $9.88 and a 200-day moving average price of $9.84. Biotech Acquisition has a 52-week low of $8.30 and a 52-week high of $10.41.
About Biotech Acquisition
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
- Get a free copy of the StockNews.com research report on Biotech Acquisition (BIOT)
- 3 Airline Stocks Stuck in a Holding Pattern
- Roku Stock is Down but Not Out
- Is Ford Rolling To A Rebound After Its Q3 Warning
- If You’re Hungry for Value, Take a Bite on Ruth’s Hospitality Grp
- Has AMD stock stock fallen too far?
Receive News & Ratings for Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.